Both DCIS and IBC tumors showed subtype specific characteristics such as higher proliferation and lower differentiation in basal-like and HER2-enriched subtypes when compared with luminal A. In general, DCIS received lower stromal and EMT scores compared with IBC. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.